Marshall Wace North America’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-24,133
| Closed | -$352K | – | 1429 |
|
|
2021
Q1 | $352K | Buy |
+24,133
| New | +$352K | ﹤0.01% | 1246 |
|
|
2018
Q4 | – | Sell |
-21,466
| Closed | -$354K | – | 1490 |
|
|
2018
Q3 | $354K | Sell |
21,466
-618,793
| -97% | -$10.2M | ﹤0.01% | 761 |
|
|
2018
Q2 | $8.96M | Buy |
640,259
+625,100
| +4,124% | +$8.75M | 0.05% | 353 |
|
|
2018
Q1 | $168K | Buy |
15,159
+3,647
| +32% | +$40.4K | ﹤0.01% | 1348 |
|
|
2017
Q4 | $101K | Buy |
+11,512
| New | +$101K | ﹤0.01% | 1315 |
|
|
2017
Q2 | – | Sell |
-63,374
| Closed | -$1.33M | – | 1305 |
|
|
2017
Q1 | $1.33M | Buy |
+63,374
| New | +$1.33M | 0.01% | 652 |
|